Connect with us

Health

BioNTech Reports Breakthrough In Treating Multiple Sclerosis With Another MRNA Vaccine – Kaiser Health News

After partnering with Pfizer on the mRNA technique in the first covid vaccine, the German company claims its experiment in treating lab mice with another mRNA vaccine…

Published

on

post featured image

After partnering with Pfizer on the mRNA technique in the first covid vaccine, the German company claims its experiment in treating lab mice with another mRNA vaccine stopped symptoms of the debilitating disease.
TheWeek:
Vaccine Maker BioNTech Reports Potential Multiple Sclerosis BreakthroughBioNTech, the German biotechnology company that paired with Pfizer to develop the first COVID-19 vaccine approved in the U.S., reports in the journal Science that a new vaccine using the same mRNA technique…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending